Pharma in review: trending stories 6/21/19

June 21, 2019

FDA slaps Indian manufacturer with 10 observations

The FDA observations are piling up for one of India’s biggest generic drug manufacturers.

Novartis' secret settlement for kickbacks revealed 
Confidential settlement talks over allegations that the company paid doctors to market drugs were revealed when a letter written to U.S. District Judge was accidentally filed.
Amgen, Lilly, Merck sue HHS

Amgen, Eli Lilly and Merck sued the Department of Health and Human Services in an attempt to block new rules requiring that drugmakers disclose the list price of their drugs in television ads

Catalyst sues FDA for approving rival drug

The drama surrounding rival treatments for a rare autoimmune disease is mounting.

Pharma's budding opportunity

Why the industry is forming bonds with CBD